MAG, is a protein expressed in myelin that inhibits neurite outgrowth and axon regeneration via interactions with neuronal receptors (e.g., NgR, paired Ig-like receptor B). Refanezumab neutralizes this inhibitory signal, potentially enabling axonal regrowth and synaptic reconnection in damaged nervous tissues.